Overview

High-dose Chemotherapy and Stem Cell Transplantation for Central Nervous System (CNS) Relapse of Aggressive Lymphomas

Status:
Unknown status

Trial end date:
2012-10-01

Target enrollment:

Participant gender:

Summary

Central nervous system (CNS) relapses of aggressive lymphomas are a rare but devastating complication. There is no therapy standard, conventional approaches are palliative. This study investigates an intensive chemotherapy with CNS penetrating drugs followed by high-dose chemotherapy and autologous stem cell transplantation as a potentially curative approach.

Phase:

Phase 2

Details

Lead Sponsor:

Charite University, Berlin, Germany

Treatments:

Ifosfamide